Xcell Therapeutics (XKRX:373110) Interest Expense : ₩-81 Mil (TTM As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Xcell Therapeutics Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Xcell Therapeutics's interest expense for the three months ended in Dec. 2024 was ₩ -1 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2024 was ₩-81 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Xcell Therapeutics's Operating Income for the three months ended in Dec. 2024 was ₩ -2,499 Mil. Xcell Therapeutics's Interest Expense for the three months ended in Dec. 2024 was ₩ -1 Mil. Xcell Therapeutics did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Xcell Therapeutics Interest Expense Historical Data

The historical data trend for Xcell Therapeutics's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xcell Therapeutics Interest Expense Chart

Xcell Therapeutics Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Interest Expense

Get a 7-Day Free Trial

-827.41

-179.78

-2.89

-3.12

-4.40

Xcell Therapeutics Quarterly Data
	Dec19	Dec20	Dec21	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Interest Expense	Get a 7-Day Free Trial							-0.86	-77.81	-1.15	-1.17	-1.18

Xcell Therapeutics Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-81 Mil.

Xcell Therapeutics (XKRX:373110) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Xcell Therapeutics's Interest Expense for the three months ended in Dec. 2024 was ₩-1 Mil. Its Operating Income for the three months ended in Dec. 2024 was ₩-2,499 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2024 was ₩1,648 Mil.

Xcell Therapeutics's Interest Coverage for the quarter that ended in Dec. 2024 is calculated as

Xcell Therapeutics did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Xcell Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Xcell Therapeutics Inc (XKRX:373110) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

333, Yeongdong-daero, Gangnam-gu, Seoul, KOR, 06188

Website

http://www.xcell.media

Xcell Therapeutics Inc operates as a research company engaged in development of regenerative medicines. The company is developing proliferation media for various animal cell types.

Xcell Therapeutics Headlines

No Headlines